Physician profile
Gregory J Pamel
NPI 1871564963
$11,275.72
in general payments reported to CMS, 2019-2025
14 companies · $9,262 in 2025
The $9,262 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $40.07 · 2021: $116 · 2022: $470 · 2023: $380 · 2024: $780 · 2025: $9,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,845 · Food and Beverage: $1,485 · Education: $60.00 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,844.92 |
| Food and Beverage | $1,485.46 |
| Education | $60.00 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $8,844.92 | 2025 | |
| Rxsight INC | $916.92 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $362.25 | 2019-2025 | Clareon |
| Sun Pharmaceutical Industries INC. | $319.40 | 2019-2025 | Cequa |
| Abbvie INC. | $199.36 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $138.22 | 2024-2025 | Miebo, Xiidra |
| Dompe US, INC. | $111.56 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $106.21 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $96.71 | 2024 | Xdemvy |
| Allergan, INC. | $78.90 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $40.21 | 2019-2023 | Tecnis Iol, Tecnis Iol, Catalys System |
| Shire North American Group INC | $23.50 | 2019 | |
| Ocular Therapeutix, INC. | $19.44 | 2019 | |
| Harrow Eye, LLC | $18.12 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Pamel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.